Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Reformed lyophylization preparation of recombinant staphylokinase (r-Sak), its preparing method and application

A technology of freeze-dried preparation and staphylokinase, which is applied in the field of biopharmaceuticals

Inactive Publication Date: 2003-10-08
BEIJING YILING BIOENG
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are currently some commercially available thrombolytic drugs clinically, there are still many problems to be solved urgently in terms of their thrombolytic effect, specificity of thrombolysis and drug price.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] The technical content of the present invention is described in detail below in conjunction with embodiment:

[0026] (1), construction of recombinant staphylokinase engineering bacteria:

[0027] The present invention chooses to use Staphylococcus aureus 1697 (taken from the strain preservation center of Institute of Microbiology, Chinese Academy of Sciences) to carry out the isolation of chromosomal DNA, and takes 0.5ml of Staphylococcus aureus 1697 to inoculate in 100ml of LB culture medium, shake at 37°C Cultivate overnight, collect the cells by centrifugation at 7000rpm at 4°C for 8 minutes, wash the cells once with 20ml TE, resuspend the cells in 20ml TE, add 120μl proteinase K and mix well, add 2.2ml 10% SDS and mix well, incubate at 37°C for 1 hour, Extract once with an equal volume of phenol (mix upside down for 1 minute), use 0.1 volume of 3M NaAc (pH5.2), and an equal volume of isopropanol, precipitate for 2 hours, centrifuge at 12000 rpm at 4 ° C for 10 minut...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A freeze-dried preparation of recombinant glucokinase in the form free dried powder, injection, lipoplasm, or microcapsule for thrombolytic purpose contains the glucokinase with mutation of amino acids at positions 7, 3 and 43, and one or more of mannitol, phosphate, EDTA and sodium chloride. Its preparing process is also disclosed.

Description

technical field [0001] The invention relates to a recombinant staphylokinase freeze-dried preparation, its preparation method and application as a thrombolytic drug, belonging to the technical field of biopharmaceuticals. Background technique [0002] Cardiovascular and cerebrovascular diseases are currently the number one killer that endangers people's health, and thrombotic diseases such as acute myocardial infarction are the main causes of death of patients. Although there are some commercially available thrombolytic drugs in clinical practice, there are still many problems to be solved urgently in terms of their thrombolytic effect, specificity of thrombolysis and drug price. Staphylokinase (Staphylokinase, referred to as SAK) is a protein produced by Staphylococcus aureus with a molecular weight of 15.5KD. It can specifically bind to plasminogen, form a complex, and activate plasminogen to become Plasmin specifically degrades fibrin and dissolves thrombus. According t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/49A61P9/00C12N1/21C12N9/70C12N15/58C12N15/70
Inventor 吴以岭
Owner BEIJING YILING BIOENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com